On the magnetic field architecture required to capture superparamagnetic nanoparticles in a microcapillary flow
Source abstract
Abstract
The magnetic field required for the capture of superparamagnetic nanoparticles flowing in a microcapillary array under a constant pressure regime was investigated in vitro. It was found that the nanoparticles were captured in locations that varied significantly in magnetic field strength, and that the location of capture was strongly related to the net volumetric flow through the microcapillary array. A hypothesis is presented to explain these data in which the magnetic field of the trapping Neodymium Iron Boron (NdFeB) block magnet is divided into two zones that act differently on the nanoparticles. In the first ‘steering zone’, nanoparticles are moved closer to the capillary wall where they can be captured downstream in the second ‘capture zone’. This hypothesis can be used in the future to design magnetic field shapes for more effective particle capture at higher flow rates with lower field strengths.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. Clime L, Le Drogoff B, Zhao S et al (2008) Magnetic nanocarriers: from material design to magnetic manipulation. Int J Nanotechnol 5(9–12):1268–1305. doi: 10.1504/IJNT.2008.01983910.1504/IJNT.2008.019839 ↗
2. Connolly J, St Pierre TG, Dobson J (2005) Experimental evaluation of the magnetic properties of commercially available magnetic microspheres. Biomed Mater Eng 15(6):421–431
3. Darton NJ, Hallmark B, Han X et al (2008a) The in-flow capture of superparamagnetic nanoparticles for targeting of gene therapeutics. In: American institute of physics conference proceedings, vol 1025, pp 20–2710.1063/1.2956814 ↗
4. Darton NJ, Hallmark B, Han X et al (2008b) The in-flow capture of superparamagnetic nanoparticles for targeting therapeutics. Nanomedicine NBM 4(1):19–2910.1016/j.nano.2007.11.001 ↗
5. Darton NJ, Hallmark B, James T et al (2009) Magnetic capture of superparamagnetic nanoparticles in a constant pressure microcapillary flow. J Magn Magn Mater. doi: 10.1016/j.jmmm.2009.02.088
6. Furlani EJ, Furlani EP (2007) A model for predicting magnetic targeting of multifunctional particles in the microvasculature. J Magn Magn Mater 312(1):187–193. doi: 10.1016/j.jmmm.2006.09.02610.1016/j.jmmm.2006.09.026 ↗
7. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021. doi: 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
8. Hallmark B, Gadala-Maria F, Mackley MR (2005a) The melt processing of polymer microcapillary film (MCF). J Non Newton Fluid 128(2–3):83–98. doi: 10.1016/j.jnnfm.2005.03.01310.1016/j.jnnfm.2005.03.013 ↗
9. Hallmark B, Mackley MR, Gadala-Maria F (2005b) Hollow microcapillary arrays in thin plastic films. Adv Eng Mater 7:545–547. doi: 10.1002/adem.20040015410.1002/adem.200400154 ↗
10. Hallmark B, Darton NJ, Han X et al (2008) Observation and modelling of capillary flow occlusion resulting from the capture of superparamagnetic nanoparticles in a magnetic field. Chem Eng Sci 63(15):3960–3965. doi: 10.1016/j.ces.2008.04.05710.1016/j.ces.2008.04.057 ↗
11. Kikura H, Matsushita J, Kakuta N et al (2007) Cluster formation of ferromagnetic nano-particles in micro-capillary flow. J Mater Process Technol 181(1–3):93–98. doi: 10.1016/j.jmatprotec.2006.03.01310.1016/j.jmatprotec.2006.03.013 ↗
12. Le Drogoff B, Clime L, Veres T (2008) The influence of magnetic carrier size on the performance of microfluidic integrated micro-electromagnetic traps. Microfluid Nanofluidics 5(3):373–381. doi: 10.1007/s10404-007-0249-110.1007/s10404-007-0249-1 ↗
13. Li XL, Yao KL, Liu HR et al (2007) The investigation of capture behaviors of different shape magnetic sources in the high-gradient magnetic field. J Magn Magn Mater 311(2):481–488. doi: 10.1016/j.jmmm.2006.07.04010.1016/j.jmmm.2006.07.040 ↗
14. Liu J, Flores GA, Sheng RS (2001) In-vitro investigation of blood embolization in cancer treatment using magnetorheological fluids. J Magn Magn Mater 225(1–2):209–217. doi: 10.1016/S0304-8853(00)01260-910.1016/S0304-8853(00)01260-9 ↗
15. Lubbe AS, Bergemann C, Riess H et al (1996) Clinical experiences with magnetic drag targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56(20):4686–4693
16. Lubbe AS, Bergemann C, Brock J et al (1999) Physiological aspects in magnetic drug-targeting. J Magn Magn Mater 194(1–3):149–155. doi: 10.1016/S0304-8853(98)00574-510.1016/S0304-8853(98)00574-5 ↗
17. Ma ZY, Guan YP, Liu HZ (2006) Superparamagnetic silica nanoparticles with immobilized metal affinity ligands for protein adsorption. J Magn Magn Mater 301(2):469–477. doi: 10.1016/j.jmmm.2005.07.02710.1016/j.jmmm.2005.07.027 ↗
18. Sako M, Hirota S, Ohtsuki S (1986) Clinical evaluation of ferromagnetic microembolization for the treatment of hepatocellular carcinoma. Ann Radiol (Paris) 29(2):200–204
19. Shapiro B, Probst R, Potts HE et al (2007) Control to concentrate drug-coated magnetic particles to deep-tissue tumors for targeted cancer chemotherapy. In: Proceedings of the 46th Ieee conference on decision and control, 1–14 Dec 2007, pp 5126–5131
20. Sheng R, Flores GA, Liu J (1999) In vitro investigation of a novel cancer therapeutic method using embolizing properties of magnetorheological fluids. J Magn Magn Mater 194(1–3):167–175. doi: 10.1016/S0304-8853(98)00565-410.1016/S0304-8853(98)00565-4 ↗
21. Udrea LE, Strachan NJ, Badescu V et al (2006) An in vitro study of magnetic particle targeting in small blood vessels. Phys Med Biol 51(19):4869–4881. doi: 10.1088/0031-9155/51/19/01010.1088/0031-9155/51/19/010 ↗
22. Voltairas PA, Fotiadis DI, Michalis LK (2002) Hydrodynamics of magnetic drug targeting. J Biomech 35(6):813–821. doi: 10.1016/S0021-9290(02)00034-910.1016/S0021-9290(02)00034-9 ↗
23. Wilson MW, Kerlan RK, Fidelman NA et al (2004) Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite—initial experience with four patients. Radiology 230(1):287–293. doi: 10.1148/radiol.230102149310.1148/radiol.2301021493 ↗